Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study
- PMID: 24145874
- DOI: 10.1093/cid/cit694
Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study
Abstract
Background: Human immunodeficiency virus type 1 (HIV-1) transmitted drug resistance (TDR) can compromise antiretroviral therapy (ART) and thus represents an important public health concern. Typically, sources of TDR remain unknown, but they can be characterized with molecular epidemiologic approaches. We used the highly representative Swiss HIV Cohort Study (SHCS) and linked drug resistance database (SHCS-DRDB) to analyze sources of TDR.
Methods: ART-naive men who have sex with men with infection date estimates between 1996 and 2009 were chosen for surveillance of TDR in HIV-1 subtype B (N = 1674), as the SHCS-DRDB contains pre-ART genotypic resistance tests for >69% of this surveillance population. A phylogeny was inferred using pol sequences from surveillance patients and all subtype B sequences from the SHCS-DRDB (6934 additional patients). Potential sources of TDR were identified based on phylogenetic clustering, shared resistance mutations, genetic distance, and estimated infection dates.
Results: One hundred forty of 1674 (8.4%) surveillance patients carried virus with TDR; 86 of 140 (61.4%) were assigned to clusters. Potential sources of TDR were found for 50 of 86 (58.1%) of these patients. ART-naive patients constitute 56 of 66 (84.8%) potential sources and were significantly overrepresented among sources (odds ratio, 6.43 [95% confidence interval, 3.22-12.82]; P < .001). Particularly large transmission clusters were observed for the L90M mutation, and the spread of L90M continued even after the near cessation of antiretroviral use selecting for that mutation. Three clusters showed evidence of reversion of K103N or T215Y/F.
Conclusions: Many individuals harboring viral TDR belonged to transmission clusters with other Swiss patients, indicating substantial domestic transmission of TDR in Switzerland. Most TDR in clusters could be linked to sources, indicating good surveillance of TDR in the SHCS-DRDB. Most TDR sources were ART naive. This, and the presence of long TDR transmission chains, suggests that resistance mutations are frequently transmitted among untreated individuals, highlighting the importance of early diagnosis and treatment.
Keywords: genotypic resistance testing; molecular epidemiology; transmitted antiretroviral drug resistance.
Similar articles
-
Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.Clin Microbiol Infect. 2013 Dec;19(12):E523-32. doi: 10.1111/1469-0691.12264. Epub 2013 Jun 19. Clin Microbiol Infect. 2013. PMID: 23782115
-
High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.J Antimicrob Chemother. 2012 May;67(5):1250-3. doi: 10.1093/jac/dks013. Epub 2012 Feb 1. J Antimicrob Chemother. 2012. PMID: 22302564
-
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.J Infect Dis. 2015 Jul 1;212(1):28-38. doi: 10.1093/infdis/jiv012. Epub 2015 Jan 9. J Infect Dis. 2015. PMID: 25576600
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
HIV-1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates.J Int AIDS Soc. 2020 Sep;23(9):e25611. doi: 10.1002/jia2.25611. J Int AIDS Soc. 2020. PMID: 32936523 Free PMC article. Review.
Cited by
-
Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland.Sci Rep. 2016 Jun 14;6:27580. doi: 10.1038/srep27580. Sci Rep. 2016. PMID: 27297284 Free PMC article.
-
Editorial Commentary: The Irreversibility of HIV Drug Resistance.Clin Infect Dis. 2015 Sep 1;61(5):837-9. doi: 10.1093/cid/civ400. Epub 2015 May 19. Clin Infect Dis. 2015. PMID: 25991467 Free PMC article. No abstract available.
-
Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort.PLoS One. 2019 Jan 16;14(1):e0209605. doi: 10.1371/journal.pone.0209605. eCollection 2019. PLoS One. 2019. PMID: 30650082 Free PMC article.
-
Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations.Viruses. 2020 Oct 30;12(11):1238. doi: 10.3390/v12111238. Viruses. 2020. PMID: 33143301 Free PMC article.
-
A phylogenetic assessment of HIV-1 transmission trends among people who inject drugs from Coastal and Nairobi, Kenya.Virus Evol. 2024 Nov 11;10(1):veae092. doi: 10.1093/ve/veae092. eCollection 2024. Virus Evol. 2024. PMID: 39678353 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical